Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers

Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers

Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers, Published online: 16 May 2018; doi:10.1038/s41416-018-0082-1

Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers

https://ift.tt/2Ij3MDE